SCICLONE PHARMACEUTICALS INC Accrued Liabilities, Current
SCICLONE PHARMACEUTICALS INC had Accrued Liabilities, Current of $20.56 million as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2017-08-09
- 2017-06-30: Accrued Liabilities, Current $20.56M.
- 2017-03-31: Accrued Liabilities, Current $18.05M.
- 2016-12-31: Accrued Liabilities, Current $22.80M.
- 2016-09-30: Accrued Liabilities, Current $19.88M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2017-06-30 | $20.56M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $18.05M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $22.80M 10-Q · filed 2017-08-09 | |
| 2016-09-30 | $19.88M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $18.76M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $17.38M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $32.15M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $32.19M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $29.87M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $16.32M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $20.54M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $19.59M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $16.73M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $15.83M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $20.94M 10-K · filed 2015-03-12 | $21.46M 10-K · filed 2014-03-17 |
| 2013-09-30 | $20.57M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $17.94M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $19.62M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $21.43M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $20.74M 10-Q/A · filed 2013-04-01 | $20.52M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $18.41M 10-Q/A · filed 2013-04-01 | $18.09M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $19.33M 10-Q/A · filed 2013-04-01 | $18.39M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $18.36M 10-Q/A · filed 2013-04-01 | $17.19M 10-K · filed 2012-03-15 |
| 2011-09-30 | $15.98M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $14.56M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $8.25M 10-K · filed 2012-03-15 |